NC_045512	AA	Alignment	NC_028806	NC_038294	AY714217	FJ647218	NC_004718	NC_038861	DQ112226	JX504050	AY463059	AJ271965	NC_002306	KU740200	MN996528	KF367457	NC_019843	NC_003436	KU182965	MG772934	AY994055	DQ022305	MN996527	FJ647223	AY597011	Variant	Genome	Annotation	Impact	Reference
1	M	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	no	28274	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
2	S	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	no	28277	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
3	D	3	0	0	3	3	3	0	0	0	3	0	0	0	3	3	0	0	0	3	0	3	3	3	3	no	28280	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
4	N	4	0	0	4	4	4	0	0	0	4	0	0	0	4	4	0	0	0	4	0	4	4	4	4	no	28283	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
5	G	5	0	0	5	5	5	0	0	0	5	0	0	0	5	5	0	0	0	5	0	5	5	5	5	no	28286	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
6	P	6	0	0	6	6	6	0	0	0	6	0	0	0	6	6	0	0	0	6	0	6	6	6	6	no	28289	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
7	Q	7	0	0	7	7	7	0	0	0	7	0	0	0	7	7	0	0	0	7	0	7	7	7	7	no	28292	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
8	N	18	0	0	9	18	9	0	0	0	9	0	0	0	8	9	0	0	0	8	0	8	8	18	17	no	28295	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
9	Q	19	0	3	10	19	10	0	0	0	10	0	0	3	9	10	3	0	3	9	0	9	9	19	18	no	28298	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
10	R	20	0	4	11	20	11	0	0	0	11	0	0	4	10	11	4	0	4	10	0	10	10	20	19	no	28301	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
11	N	23	3	5	12	23	12	3	3	0	12	3	3	5	11	12	5	0	5	11	3	11	11	23	20	no	28304	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
12	A	24	4	6	13	24	13	4	4	0	13	4	4	6	12	13	6	0	6	12	4	12	12	24	21	no	28307	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
13	P	25	5	7	14	25	14	5	5	0	14	5	5	7	13	14	7	0	7	13	5	13	13	25	22	no	28310	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
14	R	27	7	9	15	27	15	7	7	3	15	7	7	9	14	15	9	3	9	14	7	14	14	27	24	no	28313	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
15	I	28	8	10	16	28	16	8	8	4	16	8	8	10	15	16	10	4	10	15	8	15	15	28	25	no	28316	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
16	T	29	9	11	17	29	17	9	9	5	17	9	9	11	16	17	11	5	11	16	9	16	16	29	26	no	28319	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
17	F	30	10	12	18	30	18	10	10	6	18	10	10	12	17	18	12	6	12	17	10	17	17	30	27	no	28322	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
18	G	31	11	13	19	31	19	11	11	7	19	11	11	13	18	19	13	7	13	18	11	18	18	31	28	no	28325	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
19	G	32	12	14	20	32	20	12	12	8	20	12	12	14	19	20	14	8	14	19	12	19	19	32	29	no	28328	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
20	P	33	13	15	21	33	21	13	13	9	21	13	13	15	20	21	15	0	15	20	13	20	20	33	30	no	28331	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
21	S	34	14	16	22	34	22	14	14	0	22	14	14	16	21	22	16	0	16	21	14	21	21	34	31	no	28334	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
22	D	35	15	17	23	35	23	15	15	0	23	15	15	17	22	23	17	0	17	22	15	22	22	35	32	no	28337	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
23	S	36	16	18	24	36	24	16	16	0	24	16	16	18	23	24	18	0	18	23	16	23	23	36	33	no	28340	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
24	T	37	17	19	25	37	25	17	17	0	25	17	17	19	24	25	19	0	19	24	17	24	24	37	34	no	28343	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
25	G	39	19	20	26	38	26	19	19	0	26	19	19	20	25	26	20	0	20	25	19	25	25	38	35	no	28346	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
26	S	40	20	21	27	39	27	20	20	0	27	20	20	21	26	27	21	0	21	26	20	26	26	39	36	no	28349	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
27	N	41	21	22	28	40	28	21	21	0	28	21	21	22	27	28	22	0	22	27	21	27	27	40	37	no	28352	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
28	Q	42	22	23	29	41	29	22	22	0	29	22	22	23	28	29	23	0	23	28	22	28	28	41	38	no	28355	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
29	N	43	23	24	30	42	30	23	23	0	30	23	23	24	29	30	24	0	24	29	23	29	29	42	39	no	28358	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
30	G	44	24	25	31	43	31	24	24	10	31	24	24	25	30	31	25	9	25	30	24	30	30	43	40	no	28361	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
31	E	45	25	26	32	44	32	25	25	11	32	25	25	26	31	32	26	10	26	31	25	31	31	44	41	no	28364	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
32	R	46	26	27	33	45	33	26	26	12	33	26	26	27	32	33	27	11	27	32	26	32	32	45	42	no	28367	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
33	S	47	0	0	34	0	34	0	0	0	34	0	0	0	33	34	0	0	0	33	0	33	33	0	0	no	28370	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
34	G	48	27	28	35	46	35	27	27	13	35	27	27	28	34	35	28	12	28	34	27	34	34	46	43	no	28373	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
35	A	49	28	29	36	47	36	28	28	14	36	28	28	29	35	36	29	13	29	35	28	35	35	47	44	no	28376	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
36	R	50	29	30	37	48	37	29	29	15	37	29	29	30	36	37	30	14	30	36	29	36	36	48	45	no	28379	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
37	S	51	30	31	38	49	38	30	30	16	38	30	30	31	37	38	31	0	31	37	30	37	37	49	46	no	28382	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
38	K	52	31	32	39	50	39	31	31	17	39	31	31	32	38	39	32	0	32	38	31	38	38	50	47	no	28385	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
39	Q	53	0	0	40	51	40	0	0	0	40	0	0	0	39	40	0	0	0	39	0	39	39	51	48	no	28388	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
40	R	57	0	0	41	55	41	0	0	0	41	0	0	0	40	41	0	0	0	40	0	40	40	55	52	no	28391	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
41	R	58	0	0	42	56	42	0	0	0	42	0	0	0	41	42	0	0	0	41	0	41	41	56	53	no	28394	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
42	P	59	32	33	43	57	43	32	32	18	43	32	32	33	42	43	33	15	33	42	32	42	42	57	54	no	28397	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
43	Q	61	0	34	44	59	44	0	0	0	44	0	0	34	43	44	34	0	34	43	0	43	43	59	55	no	28400	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
44	G	62	0	35	45	60	45	0	0	0	45	0	0	35	44	45	35	0	35	44	0	44	44	60	56	no	28403	NTD RNA-Binding domain [1] ;		[1](10.1016/j.jmb.2007.02.069)
45	L	63	0	36	46	61	46	0	0	0	46	0	0	36	45	46	36	0	36	45	0	45	45	61	57	no	28406	NTD RNA-Binding domain [1] ;		[1](10.1016/j.jmb.2007.02.069)
46	P	64	0	37	47	62	47	0	0	0	47	0	0	37	46	47	37	0	37	46	0	46	46	62	58	no	28409	NTD RNA-Binding domain [1] ;		[1](10.1016/j.jmb.2007.02.069)
47	N	65	0	38	48	63	48	0	0	0	48	0	0	38	47	48	38	0	38	47	0	47	47	63	59	no	28412	NTD RNA-Binding domain [1] ;		[1](10.1016/j.jmb.2007.02.069)
48	N	66	0	39	49	64	49	0	0	0	49	0	0	39	48	49	39	0	39	48	0	48	48	64	60	no	28415	NTD RNA-Binding domain [1] ;		[1](10.1016/j.jmb.2007.02.069)
49	T	67	0	40	50	65	50	0	0	0	50	0	0	40	49	50	40	0	40	49	0	49	49	65	61	no	28418	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
50	A	68	33	41	51	66	51	33	33	19	51	33	33	41	50	51	41	16	41	50	33	50	50	66	62	no	28421	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
51	S	69	34	42	52	67	52	34	34	20	52	34	34	42	51	52	42	17	42	51	34	51	51	67	63	no	28424	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
52	W	70	35	43	53	68	53	35	35	21	53	35	35	43	52	53	43	18	43	52	35	52	52	68	64	no	28427	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
53	F	71	36	44	54	69	54	36	36	22	54	36	36	44	53	54	44	19	44	53	36	53	53	69	65	no	28430	Hydrophobic residue [1]; NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
54	T	72	37	45	55	70	55	37	37	23	55	37	37	45	54	55	45	20	45	54	37	54	54	70	66	no	28433	Hydrophobic residue [1]; NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
55	A	73	38	46	56	71	56	38	38	24	56	38	38	46	55	56	46	21	46	55	38	55	55	71	67	no	28436	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
56	L	74	39	47	57	72	57	39	39	25	57	39	39	47	56	57	47	22	47	56	39	56	56	72	68	no	28439	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
57	T	75	40	48	58	73	58	40	40	26	58	40	40	48	57	58	48	23	48	57	40	57	57	73	69	no	28442	Hydrophobic residue [1]; NTD RNA-Binding domain [1] ; hydrophobic pocket [2]		[1](10.1021/bi036155b); [2](10.1016/j.apsb.2020.04.009) ;
58	Q	76	41	49	59	74	59	41	41	27	59	41	41	49	58	59	49	24	49	58	41	58	58	74	70	no	28445	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
59	H	78	43	50	60	76	60	43	43	29	60	43	43	50	59	60	50	26	50	59	43	59	59	76	72	no	28448	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
60	G	79	44	51	61	77	61	44	44	30	61	44	44	51	60	61	51	27	51	60	44	60	60	77	73	no	28451	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
61	K	80	45	52	62	78	62	45	45	31	62	45	45	52	61	62	52	28	52	61	45	61	61	78	74	no	28454	NTD RNA-Binding domain [1] ; hydrophobic pocket [2]		[1](10.1021/bi036155b); [2](10.1016/j.apsb.2020.04.009) ;
62	E	81	46	53	63	79	63	46	46	32	63	46	46	53	62	63	53	29	53	62	46	62	62	79	75	no	28457	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
63	D	82	47	54	64	80	64	47	47	33	64	47	47	54	63	64	54	30	54	63	47	63	63	80	76	no	28460	NTD RNA-Binding domain [1] ; hydrophobic pocket [2]		[1](10.1021/bi036155b); [2](10.1016/j.apsb.2020.04.009) ;
64	L	83	48	55	65	81	65	48	48	34	65	48	48	55	64	65	55	31	55	64	48	64	64	81	77	no	28463	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
65	K	84	49	56	66	82	66	49	49	35	66	49	49	56	65	66	56	32	56	65	49	65	65	82	78	no	28466	Hydrophobic residue [1]; NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
66	F	85	50	57	67	83	67	50	50	36	67	50	50	57	66	67	57	33	57	66	50	66	66	83	79	no	28469	"B-cell epitope,  HLA-A*02:01, HLA-B*07:02, HLA-B*08:01, HLA-B*35:01 , HLA-B*51:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
67	P	86	51	58	68	84	68	51	51	37	68	51	51	58	67	68	58	34	58	67	51	67	67	84	80	no	28472	"B-cell epitope,  HLA-A*02:01, HLA-B*07:02, HLA-B*08:01, HLA-B*35:01 , HLA-B*51:01 [1] ; Hydrophobic residue [2]; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
68	R	87	52	59	69	85	69	52	52	38	69	52	52	59	68	69	59	35	59	68	52	68	68	85	81	no	28475	"B-cell epitope,  HLA-A*02:01, HLA-B*07:02, HLA-B*08:01, HLA-B*35:01 , HLA-B*51:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
69	G	88	53	60	70	86	70	53	53	39	70	53	53	60	69	70	60	36	60	69	53	69	69	86	82	no	28478	"B-cell epitope,  HLA-A*02:01, HLA-B*07:02, HLA-B*08:01, HLA-B*35:01 , HLA-B*51:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
70	Q	89	54	61	71	87	71	54	54	40	71	54	54	61	70	71	61	37	61	70	54	70	70	87	83	no	28481	"B-cell epitope,  HLA-A*02:01, HLA-B*07:02, HLA-B*08:01, HLA-B*35:01 , HLA-B*51:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
71	G	90	55	62	72	88	72	55	55	41	72	55	55	62	71	72	62	38	62	71	55	71	71	88	84	no	28484	"B-cell epitope,  HLA-A*02:01, HLA-B*07:02, HLA-B*08:01, HLA-B*35:01 , HLA-B*51:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
72	V	91	56	63	73	89	73	56	56	42	73	56	56	63	72	73	63	39	63	72	56	72	72	89	85	no	28487	"B-cell epitope,  HLA-A*02:01, HLA-B*07:02, HLA-B*08:01, HLA-B*35:01 , HLA-B*51:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
73	P	92	57	64	74	90	74	57	57	43	74	57	57	64	73	74	64	40	64	73	57	73	73	90	86	no	28490	"B-cell epitope,  HLA-A*02:01, HLA-B*07:02, HLA-B*08:01, HLA-B*35:01 , HLA-B*51:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
74	I	93	58	65	75	91	75	58	58	44	75	58	58	65	74	75	65	41	65	74	58	74	74	91	87	no	28493	"B-cell epitope,  HLA-A*02:01, HLA-B*07:02, HLA-B*08:01, HLA-B*35:01 , HLA-B*51:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
75	N	94	59	66	76	92	76	59	59	45	76	59	59	66	75	76	66	42	66	75	59	75	75	92	88	no	28496	"B-cell epitope,  HLA-A*02:01, HLA-B*07:02, HLA-B*08:01, HLA-B*35:01 , HLA-B*51:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
76	T	95	60	67	77	93	77	60	60	46	77	60	60	67	76	77	67	43	67	76	60	76	76	93	89	no	28499	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
77	N	96	61	68	78	94	78	61	61	47	78	61	61	68	77	78	68	44	68	77	61	77	77	94	90	no	28502	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
78	S	97	0	69	79	95	79	0	0	0	79	0	0	69	78	79	69	0	69	78	0	78	78	95	91	no	28505	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
79	S	98	62	70	80	96	80	62	62	48	80	62	62	70	79	80	70	45	70	79	62	79	79	96	92	no	28508	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
80	P	99	63	71	81	97	81	63	63	49	81	63	63	71	80	81	71	46	71	80	63	80	80	97	93	no	28511	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
81	D	100	64	72	82	98	82	64	64	50	82	64	64	72	81	82	72	47	72	81	64	81	81	98	94	no	28514	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
82	D	101	65	73	83	99	83	65	65	51	83	65	65	73	82	83	73	48	73	82	65	82	82	99	95	no	28517	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
83	Q	102	66	74	84	100	84	66	66	52	84	66	66	74	83	84	74	49	74	83	66	83	83	100	96	no	28520	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
84	I	103	67	75	85	101	85	67	67	53	85	67	67	75	84	85	75	50	75	84	67	84	84	101	97	no	28523	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
85	G	104	68	76	86	102	86	68	68	54	86	68	68	76	85	86	76	51	76	85	68	85	85	102	98	no	28526	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
86	Y	105	69	77	87	103	87	69	69	55	87	69	69	77	86	87	77	52	77	86	69	86	86	103	99	no	28529	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
87	Y	106	70	78	88	104	88	70	70	56	88	70	70	78	87	88	78	53	78	87	70	87	87	104	100	no	28532	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
88	R	107	71	79	89	105	89	71	71	57	89	71	71	79	88	89	79	54	79	88	71	88	88	105	101	no	28535	Hydrophobic residue [1];  NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
89	R	108	72	80	90	106	90	72	72	58	90	72	72	80	89	90	80	55	80	89	72	89	89	106	102	no	28538	NTD RNA-Binding domain [1] ; may contribute to guanosine base recognition [2] ; 		[1](10.1021/bi036155b); [2](10.1016/j.apsb.2020.04.009) ;
90	A	109	73	81	91	107	91	73	73	59	91	73	73	81	90	91	81	56	81	90	73	90	90	107	103	no	28541	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
91	T	110	74	82	92	108	92	74	74	60	92	74	74	82	91	92	82	57	82	91	74	91	91	108	104	no	28544	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
92	R	111	75	83	93	109	93	75	75	61	93	75	75	83	92	93	83	58	83	92	75	92	92	109	105	no	28547	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
93	R	112	0	84	94	110	94	0	0	0	94	0	0	84	93	94	84	0	84	93	0	93	93	110	106	no	28550	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
94	I	114	76	85	95	112	95	76	76	62	95	76	76	85	94	95	85	59	85	94	76	94	94	112	108	no	28553	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
95	R	115	77	86	96	113	96	77	77	63	96	77	77	86	95	96	86	60	86	95	77	95	95	113	109	no	28556	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
96	G	116	78	87	97	114	97	78	78	64	97	78	78	87	96	97	87	61	87	96	78	96	96	114	110	no	28559	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
97	G	117	79	88	98	115	98	79	79	65	98	79	79	88	97	98	88	62	88	97	79	97	97	115	111	no	28562	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
98	D	118	80	89	99	116	99	80	80	66	99	80	80	89	98	99	89	63	89	98	80	98	98	116	112	no	28565	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
99	G	119	81	90	100	117	100	81	81	67	100	81	81	90	99	100	90	64	90	99	81	99	99	117	113	no	28568	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
100	K	120	82	0	101	118	101	82	82	68	101	82	82	0	100	101	0	65	0	100	82	100	100	118	114	no	28571	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
101	M	121	83	91	102	119	102	83	83	69	102	83	83	91	101	102	91	66	91	101	83	101	101	119	115	no	28574	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
102	K	122	84	92	103	120	103	84	84	70	103	84	84	92	102	103	92	67	92	102	84	102	102	120	116	no	28577	NTD RNA-Binding domain [1] ; hydrophobic pocket [2]		[1](10.1021/bi036155b); [2](10.1016/j.apsb.2020.04.009) ;
103	D	123	85	93	104	121	104	85	85	71	104	85	85	93	103	104	93	68	93	103	85	103	103	121	117	no	28580	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
104	L	124	86	94	105	122	105	86	86	72	105	86	86	94	104	105	94	69	94	104	86	104	104	122	118	no	28583	"B-cell epitope, HLA-A*24:02, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*23:01, HLA-A*31:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
105	S	125	87	95	106	123	106	87	87	73	106	87	87	95	105	106	95	70	95	105	87	105	105	123	119	no	28586	"B-cell epitope, HLA-A*24:02, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*23:01, HLA-A*31:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
106	P	126	88	96	107	124	107	88	88	74	107	88	88	96	106	107	96	71	96	106	88	106	106	124	120	no	28589	"B-cell epitope, HLA-A*24:02, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*23:01, HLA-A*31:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
107	R	127	89	97	108	125	108	89	89	75	108	89	89	97	107	108	97	72	97	107	89	107	107	125	121	no	28592	"B-cell epitope, HLA-A*24:02, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*23:01, HLA-A*31:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
108	W	128	90	98	109	126	109	90	90	76	109	90	90	98	108	109	98	73	98	108	90	108	108	126	122	no	28595	"B-cell epitope, HLA-A*24:02, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*23:01, HLA-A*31:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
109	Y	129	91	99	110	127	110	91	91	77	110	91	91	99	109	110	99	74	99	109	91	109	109	127	123	no	28598	"B-cell epitope, HLA-A*24:02, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*23:01, HLA-A*31:01 [1] ; Hydrophobic residue [2]; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
110	F	130	92	100	111	128	111	92	92	78	111	92	92	100	110	111	100	75	100	110	92	110	110	128	124	no	28601	"B-cell epitope, HLA-A*24:02, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*23:01, HLA-A* NTD RNA-Binding domain [2] ; 31:01 [1] ; "		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
111	Y	131	93	101	112	129	112	93	93	79	112	93	93	101	111	112	101	76	101	111	93	111	111	129	125	no	28604	"B-cell epitope, HLA-A*24:02, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*23:01, HLA-A*31:01 [1] ; Hydrophobic residue [2]; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
112	Y	132	94	102	113	130	113	94	94	80	113	94	94	102	112	113	102	77	102	112	94	112	112	130	126	no	28607	"B-cell epitope, HLA-A*24:02, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*23:01, HLA-A*31:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
113	L	133	95	103	114	131	114	95	95	81	114	95	95	103	113	114	103	78	103	113	95	113	113	131	127	no	28610	"B-cell epitope, HLA-A*24:02, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*23:01, HLA-A*31:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
114	G	134	96	104	115	132	115	96	96	82	115	96	96	104	114	115	104	79	104	114	96	114	114	132	128	no	28613	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
115	T	135	97	105	116	133	116	97	97	83	116	97	97	105	115	116	105	80	105	115	97	115	115	133	129	no	28616	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
116	G	136	98	106	117	134	117	98	98	84	117	98	98	106	116	117	106	81	106	116	98	116	116	134	130	no	28619	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
117	P	137	99	107	118	135	118	99	99	85	118	99	99	107	117	118	107	82	107	117	99	117	117	135	131	no	28622	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
118	E	138	100	108	119	136	119	100	100	86	119	100	100	108	118	119	108	83	108	118	100	118	118	136	132	no	28625	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
119	A	139	101	109	120	137	120	101	101	87	120	101	101	109	119	120	109	84	109	119	101	119	119	137	133	no	28628	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
120	G	140	102	110	121	138	121	102	102	88	121	102	102	110	120	121	110	85	110	120	102	120	120	138	134	no	28631	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
121	L	141	103	111	122	139	122	103	103	89	122	103	103	111	121	122	111	86	111	121	103	121	121	139	135	no	28634	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
122	P	142	104	112	123	140	123	104	104	90	123	104	104	112	122	123	112	87	112	122	104	122	122	140	136	no	28637	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
123	Y	143	105	113	124	141	124	105	105	91	124	105	105	113	123	124	113	88	113	123	105	123	123	141	137	no	28640	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
124	G	144	106	114	125	142	125	106	106	92	125	106	106	114	124	125	114	89	114	124	106	124	124	142	138	no	28643	NTD RNA-Binding domain [1] ; hydrophobic pocket [2]		[1](10.1021/bi036155b); [2](10.1016/j.apsb.2020.04.009) ;
125	A	145	107	115	126	143	126	107	107	93	126	107	107	115	125	126	115	90	115	125	107	125	125	143	139	no	28646	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
126	N	146	108	116	127	144	127	108	108	94	127	108	108	116	126	127	116	91	116	126	108	126	126	144	140	no	28649	NTD RNA-Binding domain [1] ; hydrophobic pocket [2]		[1](10.1021/bi036155b); [2](10.1016/j.apsb.2020.04.009) ;
127	K	147	109	117	128	145	128	109	109	95	128	109	109	117	127	128	117	92	117	127	109	127	127	145	141	no	28652	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
128	D	148	110	118	129	146	129	110	110	96	129	110	110	118	128	129	118	93	118	128	110	128	128	146	142	no	28655	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
129	G	149	111	119	130	147	130	111	111	97	130	111	111	119	129	130	119	94	119	129	111	129	129	147	143	no	28658	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
130	I	150	112	120	131	148	131	112	112	98	131	112	112	120	130	131	120	95	120	130	112	130	130	148	144	no	28661	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
131	I	151	113	121	132	149	132	113	113	99	132	113	113	121	131	132	121	96	121	131	113	131	131	149	145	no	28664	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
132	W	152	114	122	133	150	133	114	114	100	133	114	114	122	132	133	122	97	122	132	114	132	132	150	146	no	28667	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
133	V	153	115	123	134	151	134	115	115	101	134	115	115	123	133	134	123	98	123	133	115	133	133	151	147	no	28670	Hydrophobic residue [1]; NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
134	A	154	116	124	135	152	135	116	116	102	135	116	116	124	134	135	124	99	124	134	116	134	134	152	148	no	28673	"B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
135	T	155	117	125	136	153	136	117	117	103	136	117	117	125	135	136	125	100	125	135	117	135	135	153	149	no	28676	"B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
136	E	156	118	126	137	154	137	118	118	104	137	118	118	126	136	137	126	101	126	136	118	136	136	154	150	no	28679	"B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
137	G	157	119	127	138	155	138	119	119	105	138	119	119	127	137	138	127	102	127	137	119	137	137	155	151	no	28682	"B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
138	A	158	120	128	139	156	139	120	120	106	139	120	120	128	138	139	128	103	128	138	120	138	138	156	152	no	28685	"T cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 , HLA-A*02:01 [2] ;  T-cell epitope  HLA-A*02:01  [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
139	L	159	121	129	140	157	140	121	121	107	140	121	121	129	139	140	129	104	129	139	121	139	139	157	153	no	28688	"T cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 , HLA-A*02:01 [2] ;  T-cell epitope  HLA-A*02:01  [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
140	N	160	122	130	141	158	141	122	122	108	141	122	122	130	140	141	130	105	130	140	122	140	140	158	154	no	28691	"T cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 , HLA-A*02:01 [2] ;  T-cell epitope  HLA-A*02:01  [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
141	T	161	123	131	142	159	142	123	123	109	142	123	123	131	141	142	131	106	131	141	123	141	141	159	155	no	28694	"T cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 , HLA-A*02:01 [2] ;  T-cell epitope  HLA-A*02:01  [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
142	P	162	124	132	143	160	143	124	124	110	143	124	124	132	142	143	132	107	132	142	124	142	142	160	156	no	28697	"T cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 , HLA-A*02:01 [2] ;  T-cell epitope  HLA-A*02:01  [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
143	K	163	125	133	144	161	144	125	125	111	144	125	125	133	143	144	133	108	133	143	125	143	143	161	157	no	28700	"T cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 , HLA-A*02:01 [2] ;  T-cell epitope  HLA-A*02:01  [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
144	D	164	126	134	145	162	145	126	126	112	145	126	126	134	144	145	134	109	134	144	126	144	144	162	158	no	28703	"T cell epitope [1] ; B-cell epitope, HLA-A*02:01 [2] ;  T-cell epitope  HLA-A*02:01  [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
145	H	165	0	0	146	163	146	0	0	0	146	0	0	0	145	146	0	0	0	145	0	145	145	163	159	no	28706	"T cell epitope [1] ; B-cell epitope, HLA-A*02:01 [2] ;  T-cell epitope  HLA-A*02:01  [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
146	I	166	127	135	147	164	147	127	127	113	147	127	127	135	146	147	135	110	135	146	127	146	146	164	160	no	28709	"T cell epitope [1] ; B-cell epitope, HLA-A*02:01 [2] ;  T-cell epitope  HLA-A*02:01  [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
147	G	167	128	136	148	165	148	128	128	114	148	128	128	136	147	148	136	111	136	147	128	147	147	165	161	no	28712	"B-cell epitope, HLA-A*02:01 [1] ;  T-cell epitope  HLA-A*02:01  [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
148	T	168	129	137	149	166	149	129	129	115	149	129	129	137	148	149	137	112	137	148	129	148	148	166	162	no	28715	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
149	R	169	130	138	150	167	150	130	130	116	150	130	130	138	149	150	138	113	138	149	130	149	149	167	163	no	28718	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
150	N	170	131	139	151	168	151	131	131	117	151	131	131	139	150	151	139	114	139	150	131	150	150	168	164	no	28721	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
151	P	171	0	140	152	169	152	0	0	0	152	0	0	140	151	152	140	0	140	151	0	151	151	169	165	no	28724	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
152	A	172	132	141	153	170	153	132	132	118	153	132	132	141	152	153	141	115	141	152	132	152	152	170	166	no	28727	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
153	N	173	133	142	154	171	154	133	133	119	154	133	133	142	153	154	142	116	142	153	133	153	153	171	167	no	28730	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
154	N	174	134	143	155	172	155	134	134	120	155	134	134	143	154	155	143	117	143	154	134	154	154	172	168	no	28733	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
155	A	175	135	144	156	173	156	135	135	121	156	135	135	144	155	156	144	118	144	155	135	155	155	173	169	no	28736	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
156	A	176	136	145	157	174	157	136	136	122	157	136	136	145	156	157	145	119	145	156	136	156	156	174	170	no	28739	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
157	I	177	137	146	158	175	158	137	137	123	158	137	137	146	157	158	146	120	146	157	137	157	157	175	171	no	28742	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
158	V	178	138	147	159	176	159	138	138	124	159	138	138	147	158	159	147	121	147	158	138	158	158	176	172	no	28745	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01 [1] ;  NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
159	L	179	139	148	160	177	160	139	139	125	160	139	139	148	159	160	148	122	148	159	139	159	159	177	173	no	28748	"T cell epitope [1] ;  B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01 [2] ;T-cell epitope, HLA-A*02:01 [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
160	Q	180	140	149	161	178	161	140	140	126	161	140	140	149	160	161	149	123	149	160	140	160	160	178	174	no	28751	"T cell epitope [1] ;  B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [2] ;T-cell epitope, HLA-A*02:01 [2] ; Hydrophobic residue [3]; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
161	L	181	141	150	162	179	162	141	141	127	162	141	141	150	161	162	150	124	150	161	141	161	161	179	175	no	28754	"T cell epitope [1] ;  B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [2] ;T-cell epitope, HLA-A*02:01 [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
162	P	182	0	151	163	180	163	0	0	0	163	0	0	151	162	163	151	0	151	162	0	162	162	180	176	no	28757	"T cell epitope [1] ;  B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [2] ;T-cell epitope, HLA-A*02:01 [2] ; Hydrophobic residue [3]; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
163	Q	183	0	152	164	181	164	0	0	0	164	0	0	152	163	164	152	0	152	163	0	163	163	181	177	no	28760	"T cell epitope [1] ; B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [2] ;T-cell epitope, HLA-A*02:01 [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
164	G	184	142	153	165	182	165	142	142	128	165	142	142	153	164	165	153	125	153	164	142	164	164	182	178	no	28763	"T cell epitope [1] ; B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*01:01  [2] ;T-cell epitope, HLA-A*02:01 [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
165	T	185	143	154	166	183	166	143	143	129	166	143	143	154	165	166	154	126	154	165	143	165	165	183	179	no	28766	"T cell epitope [1] ; B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*01:01 [2] ;T-cell epitope, HLA-A*02:01 [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
166	T	186	144	155	167	184	167	144	144	130	167	144	144	155	166	167	155	127	155	166	144	166	166	184	180	no	28769	"T cell epitope [1] ; B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*01:01  [2] ;T-cell epitope, HLA-A*02:01 [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
167	L	187	145	156	168	185	168	145	145	131	168	145	145	156	167	168	156	128	156	167	145	167	167	185	181	no	28772	"T cell epitope [1] ;  B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*01:01  [2] ;T-cell epitope, HLA-A*02:01 [2] ; NTD RNA-Binding domain [3] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1021/bi036155b); 
168	P	188	146	157	169	186	169	146	146	132	169	146	146	157	168	169	157	129	157	168	146	168	168	186	182	no	28775	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*01:01  [1] ;T-cell epitope, HLA-A*02:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
169	K	189	147	158	170	187	170	147	147	133	170	147	147	158	169	170	158	130	158	169	147	169	169	187	183	no	28778	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*01:01   [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
170	G	190	148	159	171	188	171	148	148	134	171	148	148	159	170	171	159	131	159	170	148	170	170	188	184	no	28781	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*01:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
171	F	191	149	160	172	189	172	149	149	135	172	149	149	160	171	172	160	132	160	171	149	171	171	189	185	no	28784	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*01:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
172	Y	192	150	161	173	190	173	150	150	136	173	150	150	161	172	173	161	133	161	172	150	172	172	190	186	no	28787	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*01:01 [1] ; Hydrophobic residue [2];  ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
173	A	193	151	162	174	191	174	151	151	137	174	151	151	162	173	174	162	134	162	173	151	173	173	191	187	no	28790	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*01:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
174	E	194	152	163	175	192	175	152	152	138	175	152	152	163	174	175	163	135	163	174	152	174	174	192	188	no	28793	"B-cell epitope, HLA-A*02:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1021/bi036155b); 
175	G	195	153	164	176	193	176	153	153	139	176	153	153	164	175	176	164	0	164	175	153	175	175	193	189	no	28796	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
176	S	196	154	165	177	194	177	154	154	140	177	154	154	165	176	177	165	0	165	176	154	176	176	194	190	no	28799	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
177	R	197	155	166	178	0	178	155	155	141	178	155	155	166	177	178	166	136	166	177	155	177	177	0	0	no	28802	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
178	G	198	156	167	179	195	179	156	156	142	179	156	156	167	178	179	167	137	167	178	156	178	178	195	191	no	28805	NTD RNA-Binding domain [1] ;		[1](10.1021/bi036155b); 
179	G	199	157	168	180	196	180	157	157	143	180	157	157	168	179	180	168	138	168	179	157	179	179	196	192	no	28808	NTD RNA-Binding domain [1] ;		[1](10.1016/j.jmb.2007.02.069)
180	S	200	158	169	181	197	181	158	158	144	181	158	158	169	180	181	169	139	169	180	158	180	180	197	193	no	28811	"B-cell epitope, HLA-A*03:01, HLA-A*11:01
HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1] ; NTD RNA-Binding domain [2] ;"		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069)
181	Q	201	159	170	182	198	182	159	159	145	182	159	159	170	181	182	170	140	170	181	159	181	181	198	194	no	28814	"B-cell epitope, HLA-A*03:01, HLA-A*11:01
HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1] ;  Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
182	A	202	160	171	183	199	183	160	160	146	183	160	160	171	182	183	171	141	171	182	160	182	182	199	195	no	28817	"B-cell epitope, HLA-A*03:01, HLA-A*11:01
HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
183	S	203	161	172	184	200	184	161	161	147	184	161	161	172	183	184	172	142	172	183	161	183	183	200	196	no	28820	"B-cell epitope, HLA-A*03:01, HLA-A*11:01
HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
184	S	204	162	173	185	201	185	162	162	148	185	162	162	173	184	185	173	143	173	184	162	184	184	201	197	no	28823	"B-cell epitope, HLA-A*03:01, HLA-A*11:01
HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
185	R	205	163	174	186	202	186	163	163	149	186	163	163	174	185	186	174	144	174	185	163	185	185	202	198	no	28826	"B-cell epitope, HLA-A*03:01, HLA-A*11:01
HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
186	S	206	164	175	187	203	187	164	164	150	187	164	164	175	186	187	175	145	175	186	164	186	186	203	199	no	28829	"B-cell epitope, HLA-A*03:01, HLA-A*11:01
HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
187	S	207	165	176	188	204	188	165	165	151	188	165	165	176	187	188	176	146	176	187	165	187	187	204	200	no	28832	"B-cell epitope, HLA-A*03:01, HLA-A*11:01
HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
188	S	208	166	177	189	205	189	166	166	152	189	166	166	177	188	189	177	147	177	188	166	188	188	205	201	no	28835	"B-cell epitope, HLA-A*03:01, HLA-A*11:01
HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
189	R	209	167	178	190	206	190	167	167	153	190	167	167	178	189	190	178	148	178	189	167	189	189	206	202	no	28838	"B-cell epitope, HLA-A*03:01, HLA-A*11:01
HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
190	S	210	168	179	191	207	191	168	168	154	191	168	168	179	190	191	179	149	179	190	168	190	190	207	203	no	28841	"B-cell epitope, HLA-A*03:01, HLA-A*11:01
HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
191	R	211	169	180	192	208	192	169	169	155	192	169	169	180	191	192	180	150	180	191	169	191	191	208	204	no	28844	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
192	N	212	170	181	193	209	193	170	170	156	193	170	170	181	192	193	181	151	181	192	170	192	192	209	205	no	28847	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
193	S	213	171	182	194	210	194	171	171	157	194	171	171	182	193	194	182	152	182	193	171	193	193	210	206	no	28850	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
194	S	214	172	183	195	211	195	172	172	158	195	172	172	183	194	195	183	153	183	194	172	194	194	211	207	no	28853	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
195	R	217	0	184	196	213	196	0	0	161	196	0	0	184	195	196	184	156	184	195	0	195	195	213	209	no	28856	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
196	N	218	0	185	197	214	197	0	0	162	197	0	0	185	196	197	185	157	185	196	0	196	196	214	210	no	28859	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
197	S	219	0	186	198	215	198	0	0	163	198	0	0	186	197	198	186	158	186	197	0	197	197	215	211	no	28862	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
198	T	220	0	187	199	0	199	0	0	164	199	0	0	187	198	199	187	159	187	198	0	198	198	0	212	no	28865	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
199	P	221	0	188	200	0	200	0	0	165	200	0	0	188	199	200	188	160	188	199	0	199	199	0	0	no	28868	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
200	G	222	0	189	201	0	201	0	0	166	201	0	0	189	200	201	189	161	189	200	0	200	200	0	0	no	28871	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
201	S	260	0	195	202	0	202	0	0	167	202	0	0	195	201	202	195	199	195	201	0	201	201	0	213	no	28874	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
202	S	261	0	196	203	216	203	0	0	168	203	0	0	196	202	203	196	200	196	202	0	202	202	216	214	no	28877	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
203	R	262	173	197	204	217	204	173	173	169	204	173	173	197	203	204	197	201	197	203	173	203	203	217	215	no	28880	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
204	G	263	174	198	205	218	205	174	174	170	205	174	174	198	204	205	198	202	198	204	174	204	204	218	216	no	28883	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
205	T	264	175	199	206	219	206	175	175	171	206	175	175	199	205	206	199	203	199	205	175	205	205	219	217	no	28886	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
206	S	265	176	200	207	220	207	176	176	172	207	176	176	200	206	207	200	204	200	206	176	206	206	220	218	no	28889	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
207	P	266	177	201	208	221	208	177	177	173	208	177	177	201	207	208	201	205	201	207	177	207	207	221	219	no	28892	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
208	A	267	178	202	209	222	209	178	178	174	209	178	178	202	208	209	202	206	202	208	178	208	208	222	220	no	28895	"B-cell epitope, HLA-B*07:02 [1] ; Inter Domain linker [2] ; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
209	R	268	179	203	210	223	210	179	179	175	210	179	179	203	209	210	203	207	203	209	179	209	209	223	221	no	28898	"B-cell epitope, HLA-B*07:02 [1] ; Inter Domain linker [2] ; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
210	M	269	180	204	211	224	211	180	180	176	211	180	180	204	210	211	204	208	204	210	180	210	210	224	222	no	28901	"B-cell epitope, HLA-B*07:02 [1] ; Inter Domain linker [2] ; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
211	A	270	181	205	212	225	212	181	181	177	212	181	181	205	211	212	205	209	205	211	181	211	211	225	223	no	28904	"B-cell epitope, HLA-B*07:02 [1] ; Inter Domain linker [2] ; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
212	G	271	182	206	213	226	213	182	182	178	213	182	182	206	212	213	206	210	206	212	182	212	212	226	224	no	28907	"B-cell epitope, HLA-B*07:02 [1] ; Inter Domain linker [2] ; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
213	N	272	183	207	214	227	214	183	183	179	214	183	183	207	213	214	207	211	207	213	183	213	213	227	225	no	28910	"B-cell epitope, HLA-B*07:02 [1] ; Inter Domain linker [2] ; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
214	G	273	184	0	215	228	215	184	184	180	215	184	184	0	214	215	0	212	208	214	184	214	214	228	226	no	28913	"B-cell epitope, HLA-B*07:02 [1] ; Inter Domain linker [2] ; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
215	G	279	186	0	216	230	216	186	186	181	216	186	185	0	215	216	0	218	210	215	185	215	215	230	228	no	28916	"T cell epitope [1] ; B-cell epitope, HLA-B*07:02 [2] ;  Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
216	D	280	187	208	217	231	217	187	187	182	217	187	186	208	216	217	208	219	211	216	186	216	216	231	229	no	28919	"T cell epitope [1] ; B-cell epitope, HLA-B*07:02 [2] ; Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
217	A	281	188	209	218	232	218	188	188	183	218	188	187	209	217	218	209	220	212	217	187	217	217	232	230	no	28922	"T cell epitope [1] ; B-cell epitope, HLA-B*07:02 [2] ; Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
218	A	282	189	210	219	233	219	189	189	184	219	189	188	210	218	219	210	221	213	218	188	218	218	233	231	no	28925	T cell epitope [1] ; Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
219	L	283	190	211	220	234	220	190	190	185	220	190	189	211	219	220	211	222	214	219	189	219	219	234	232	no	28928	"T cell epitope [1] ; B-cell epitope,  HLA-A*02:01 [2] ;  Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
220	A	284	191	212	221	235	221	191	191	186	221	191	190	212	220	221	212	223	215	220	190	220	220	235	233	no	28931	"T cell epitope [1] ; B-cell epitope,  HLA-A*02:01 [2] ; Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
221	L	285	192	213	222	236	222	192	192	187	222	192	191	213	221	222	213	224	216	221	191	221	221	236	234	no	28934	"T cell epitope [1] ; B-cell epitope,  HLA-A*02:01 [2] ; Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
222	L	286	193	214	223	237	223	193	193	188	223	193	192	214	222	223	214	225	217	222	192	222	222	237	235	no	28937	"T cell epitope [1] ; B-cell epitope,  HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;  Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
223	L	287	194	215	224	238	224	194	194	189	224	194	193	215	223	224	215	226	218	223	193	223	223	238	236	no	28940	"T cell epitope [1] ; B-cell epitope,  HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;  Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
224	L	288	195	216	225	239	225	195	195	190	225	195	194	216	224	225	216	227	219	224	194	224	224	239	237	no	28943	"T cell epitope [1] ; B-cell epitope,  HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;  Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
225	D	289	196	217	226	240	226	196	196	191	226	196	195	217	225	226	217	228	220	225	195	225	225	240	238	no	28946	"T cell epitope [1] ; B-cell epitope,  HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;  Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
226	R	290	197	218	227	241	227	197	197	192	227	197	196	218	226	227	218	229	221	226	196	226	226	241	239	no	28949	"T cell epitope [1] ; B-cell epitope,  HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;  Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
227	L	291	198	219	228	242	228	198	198	193	228	198	197	219	227	228	219	230	222	227	197	227	227	242	240	no	28952	"T cell epitope [1] ; B-cell epitope,  HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;  Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
228	N	292	199	220	229	243	229	199	199	194	229	199	198	220	228	229	220	231	223	228	198	228	228	243	241	no	28955	"T cell epitope [1] ; B-cell epitope,  HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;  Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
229	Q	293	200	221	230	244	230	200	200	195	230	200	199	221	229	230	221	232	224	229	199	229	229	244	242	no	28958	"T cell epitope [1] ; B-cell epitope,  HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;  Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
230	L	294	201	222	231	245	231	201	201	196	231	201	200	222	230	231	222	233	225	230	200	230	230	245	243	no	28961	"T cell epitope [1] ; B-cell epitope,  HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;  Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
231	E	295	202	223	232	246	232	202	202	197	232	202	201	223	231	232	223	234	226	231	201	231	231	246	244	no	28964	"T cell epitope [1] ; B-cell epitope,  HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;  Inter Domain linker [3] ; intrinsically disordered regions (IDR) [4]; "		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); [3](10.1016/j.jmb.2007.02.069); [4](10.3390/v6082991); 
232	S	296	203	224	233	247	233	203	203	198	233	203	202	224	232	233	224	235	227	232	202	232	232	247	245	no	28967	T cell epitope [1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
233	K	304	207	225	234	0	234	207	207	202	234	207	203	225	233	234	225	243	228	233	203	233	233	0	0	no	28970	T cell epitope [1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
234	M	305	208	226	235	0	235	208	208	203	235	208	204	226	234	235	226	244	229	234	204	234	234	0	0	no	28973	T cell epitope [1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
235	S	306	209	227	236	0	236	209	209	204	236	209	205	227	235	236	227	245	230	235	205	235	235	0	0	no	28976	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
236	G	307	210	228	237	0	237	210	210	205	237	210	206	228	236	237	228	246	231	236	206	236	236	0	0	no	28979	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
237	K	308	211	229	238	0	238	211	211	206	238	211	207	229	237	238	229	247	232	237	207	237	237	0	0	no	28982	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
238	G	309	212	230	239	0	239	212	212	207	239	212	208	230	238	239	230	248	233	238	208	238	238	0	0	no	28985	Inter Domain linker [1] ; intrinsically disordered regions (IDR) [2]; 		[1](10.1016/j.jmb.2007.02.069) ; [2](10.3390/v6082991); 
239	Q	310	213	231	240	0	240	213	213	208	240	213	209	231	239	240	231	249	234	239	209	239	239	0	0	no	28988	"B-cell epitope,  HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
240	Q	311	214	232	241	0	241	214	214	209	241	214	210	232	240	241	232	250	0	240	210	240	240	0	0	no	28991	"B-cell epitope,  HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
241	Q	319	218	233	242	250	242	218	218	217	242	218	214	233	241	242	233	251	0	241	214	241	241	250	0	no	28994	"B-cell epitope,  HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
242	Q	320	219	234	243	251	243	219	219	218	243	219	215	234	242	243	234	252	235	242	215	242	242	251	248	no	28997	"B-cell epitope,  HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
243	G	321	220	235	244	252	244	220	220	219	244	220	216	235	243	244	235	253	236	243	216	243	243	252	249	no	29000	"B-cell epitope,  HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
244	Q	322	221	236	245	253	245	221	221	220	245	221	217	236	244	245	236	254	237	244	217	244	244	253	250	no	29003	"B-cell epitope,  HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
245	T	323	222	237	246	254	246	222	222	221	246	222	218	237	245	246	237	255	238	245	218	245	245	254	251	no	29006	"B-cell epitope,  HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
246	V	324	223	238	247	255	247	223	223	222	247	223	219	238	246	247	238	256	239	246	219	246	246	255	252	no	29009	"B-cell epitope,  HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; Inter Domain linker [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; [3](10.3390/v6082991); 
247	T	325	224	239	248	256	248	224	224	223	248	224	220	239	247	248	239	257	240	247	220	247	247	256	253	no	29012	"B-cell epitope,  HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; Inter Domain linker [2] ;  Form hydrogen bond with  residue 269 [2] ;"		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; 
248	K	326	225	240	249	257	249	225	225	224	249	225	221	240	248	249	240	258	241	248	221	248	248	257	254	no	29015	"B-cell epitope,  HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ;  CTD dimerization domain [2] ; "		[1](10.3390/v12030254); [2](10.1016/j.jmb.2007.02.069) ; 
249	K	327	226	241	250	258	250	226	226	225	250	226	222	241	249	250	241	259	242	249	222	249	249	258	255	no	29018	"B-cell epitope,  HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1] ; CTD dimerization domain [2] ; "		[1](10.3390/v12030254);
250	S	328	227	242	251	259	251	227	227	226	251	227	223	242	250	251	242	260	243	250	223	250	250	259	256	yes	29021	 CTD dimerization domain [1] ; 		[1](10.1016/j.jmb.2007.02.069);
251	A	329	228	243	252	260	252	228	228	227	252	228	224	243	251	252	243	261	244	251	224	251	251	260	257	yes	29024	 CTD dimerization domain [1] ; 		[1](10.1016/j.jmb.2007.02.069);
252	A	330	229	244	253	261	253	229	229	228	253	229	225	244	252	253	244	262	245	252	225	252	252	261	258	yes	29027	 CTD dimerization domain [1] ; 		[1](10.1016/j.jmb.2007.02.069);
253	E	331	230	245	254	262	254	230	230	229	254	230	226	245	253	254	245	263	246	253	226	253	253	262	259	yes	29030	 CTD dimerization domain [1] ; 		[1](10.1016/j.jmb.2007.02.069);
254	A	332	231	246	255	263	255	231	231	230	255	231	227	246	254	255	246	264	247	254	227	254	254	263	260	yes	29033	 CTD dimerization domain [1] ; 		[1](10.1016/j.jmb.2007.02.069);
255	S	333	232	247	256	264	256	232	232	231	256	232	228	247	255	256	247	265	248	255	228	255	255	264	261	yes	29036	 CTD dimerization domain [1] ; 		[1](10.1016/j.jmb.2007.02.069);
256	K	345	233	248	257	269	257	233	233	232	257	233	229	248	256	257	248	277	249	256	229	256	256	269	266	yes	29039	B and T cell epitope [1] ; CTD dimerization domain [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.1016/j.jmb.2007.02.069);
257	K	346	234	249	258	270	258	234	234	233	258	234	230	249	257	258	249	278	250	257	230	257	257	270	267	yes	29042	"linker region (LKR), U-shaped β-platform, putative RNA- binding domain [1] ; B-cell epitope, [3] ; (identical in SARS-CoV-2 and SARS-Cov [2] ) ; CTD dimerization domain [4] ; "		[1](10.1128/jvi.00017-07 );  [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v12030254); [410.1016/j.jmb.2007.02.069);
258	P	347	235	250	259	271	259	235	235	234	259	235	231	250	258	259	250	279	251	258	231	258	258	271	268	yes	29045	"linker region (LKR), U-shaped β-platform, putative RNA- binding domain [1] ; B-cell epitope, [3] ;  CTD dimerization domain [2] ; "		[1](10.1128/jvi.00017-07 );  [2](10.1016/j.jmb.2007.02.069);  [3](10.3390/v12030254); 
259	R	348	236	251	260	272	260	236	236	235	260	236	232	251	259	260	251	280	252	259	232	259	259	272	269	yes	29048	B-cell epitope(identical in SARS-CoV-2 and SARS-Cov) [1] ;   linker region (LKR) [2] ;  U-shaped β-platform [2];  putative RNA- binding domain [3] ; CTD dimerization domain [4] ; 		[1](10.3390/v12030254); [2](10.1128/jvi.00017-07); [3](10.1016/j.jmb.2007.02.069) ; [4](10.1016/j.jmb.2007.02.069);
260	Q	349	237	252	261	273	261	237	237	236	261	237	233	252	260	261	252	281	253	260	233	260	260	273	270	yes	29051	B-cell epitope(identical in SARS-CoV-2 and SARS-Cov) [1] ;   linker region (LKR) [2] ;  U-shaped β-platform [2];  putative RNA- binding domain [3] ; CTD dimerization domain [4] ; Form hydrogen bond with  residue 310 [4] ;		[1](10.3390/v12030254); [2](10.1128/jvi.00017-07); [3](10.1016/j.jmb.2007.02.069) ; [4](10.1016/j.jmb.2007.02.069);
261	K	350	238	253	262	274	262	238	238	237	262	238	234	253	261	262	253	282	254	261	234	261	261	274	271	yes	29054	B-cell epitope(identical in SARS-CoV-2 and SARS-Cov) [1] ;   linker region (LKR) [2] ;  U-shaped β-platform [2];  putative RNA- binding domain [3] ; CTD dimerization domain [4] ; 		[1](10.3390/v12030254); [2](10.1128/jvi.00017-07); [3](10.1016/j.jmb.2007.02.069) ; [4](10.1016/j.jmb.2007.02.069);
262	R	351	239	254	263	275	263	239	239	238	263	239	235	254	262	263	254	283	255	262	235	262	262	275	272	yes	29057	B-cell epitope(identical in SARS-CoV-2 and SARS-Cov) [1] ;   linker region (LKR) [2] ;  U-shaped β-platform [2];  putative RNA- binding domain [3] ; CTD dimerization domain [4] ; 		[1](10.3390/v12030254); [2](10.1128/jvi.00017-07); [3](10.1016/j.jmb.2007.02.069) ; [4](10.1016/j.jmb.2007.02.069);
263	T	352	240	255	264	276	264	240	240	239	264	240	236	255	263	264	255	284	256	263	236	263	263	276	273	yes	29060	B-cell epitope(identical in SARS-CoV-2 and SARS-Cov) [1] ;   linker region (LKR) [2] ;  U-shaped β-platform [2];  putative RNA- binding domain [3] ; CTD dimerization domain [4] ; 		[1](10.3390/v12030254); [2](10.1128/jvi.00017-07); [3](10.1016/j.jmb.2007.02.069) ; [4](10.1016/j.jmb.2007.02.069);
264	A	353	241	256	265	277	265	241	241	240	265	241	237	256	264	265	256	285	257	264	237	264	264	277	274	yes	29063	B-cell epitope (identical in SARS-CoV-2 and SARS-Cov) [1] ;   linker region (LKR) [2] ;  U-shaped β-platform [2];  putative RNA- binding domain [3] ; CTD dimerization domain [4] ; Form hydrogen bond with  residue 266 [4] ;		[1](10.3390/v12030254); [2](10.1128/jvi.00017-07); [3](10.1016/j.jmb.2007.02.069) ; [4](10.1016/j.jmb.2007.02.069);
265	T	354	242	257	266	278	266	242	242	241	266	242	238	257	265	266	257	286	258	265	238	265	265	278	275	yes	29066	B-cell epitopeidentical in SARS-CoV-2 and SARS-Cov) [1] ; linker region (LKR) [1] ; U-shaped β-platform;  essential for multimerization of SARS-CoV N protein;  Phosphorylation site in IBV; ; CTD dimerization domain [5] ; 		[1](10.1128/jvi.00017-07); [2](10.1016/j.str.2005.08.021); [3](10.1007/s11373-005-9035-9); [4](10.3390/v12030254); [5](10.1016/j.jmb.2007.02.069);
266	K	355	243	258	267	279	267	243	243	242	267	243	239	258	266	267	258	287	259	266	239	266	266	279	276	yes	29069	B-cell epitope(identical in SARS-CoV-2 and SARS-Cov) [4] ; linker region (LKR) [1] ; U-shaped β-platform;  essential for multimerization of SARS-CoV N protein;  Phosphorylation site in IBV; ; CTD dimerization domain [5] ; Form hydrogen bond with Arg276 and residue 264 [5] ;		[1](10.1128/jvi.00017-07); [2](10.1016/j.str.2005.08.021); [3](10.1007/s11373-005-9035-9); [4](10.3390/v12030254); [5](10.1016/j.jmb.2007.02.069);
267	A	356	244	259	268	280	268	244	244	243	268	244	240	259	267	268	259	288	260	267	240	267	267	280	277	yes	29072	 linker region (LKR) [2]; ; CTD dimerization domain [1] ; 		c [2](10.1128/jvi.00017-07)
268	Y	357	0	260	269	281	269	0	0	244	269	0	0	260	268	269	260	289	261	268	0	268	268	281	278	yes	29075	 linker region (LKR) [2]; ; CTD dimerization domain [1] ; 		[1](10.1016/j.jmb.2007.02.069); [2](10.1128/jvi.00017-07)
269	N	358	245	261	270	282	270	245	245	245	270	245	241	261	269	270	261	290	262	269	241	269	269	282	279	yes	29078	" linker region (LKR) [2]; ; CTD dimerization domain  , core  domain stabilized by multiple hydrophobic interactions [1] ; Form hydrogen bond with  residue 247 [1] ;"		[1](10.1016/j.jmb.2007.02.069); [2](10.1128/jvi.00017-07)
270	V	359	246	262	271	283	271	246	246	246	271	246	242	262	270	271	262	291	263	270	242	270	270	283	280	yes	29081	" linker region (LKR) [2]; ; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069); [2](10.1128/jvi.00017-07)
271	T	360	247	263	272	284	272	247	247	247	272	247	243	263	271	272	263	292	264	271	243	271	271	284	281	yes	29084	" linker region (LKR) [2]; ; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069); [2](10.1128/jvi.00017-07)
272	Q	361	248	264	273	285	273	248	248	248	273	248	244	264	272	273	264	293	265	272	244	272	272	285	282	yes	29087	"linker region (LKR)[2] ; T cell epitope [1] ; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [3] ; Form hydrogen bond with  Arg276 [3] ;"		[1](10.1016/j.chom.2020.03.002); [2](10.1128/jvi.00017-07) ; [3](10.1016/j.jmb.2007.02.069);
273	A	362	249	265	274	286	274	249	249	249	274	249	245	265	273	274	265	294	266	273	245	273	273	286	283	yes	29090	"linker region (LKR)[2] ; T cell epitope [1] ; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [3] ; "		[1](10.1016/j.chom.2020.03.002); [2](10.1128/jvi.00017-07) ; [3](10.1016/j.jmb.2007.02.069);
274	F	363	250	266	275	287	275	250	250	250	275	250	246	266	274	275	266	295	267	274	246	274	274	287	284	yes	29093	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
275	G	364	251	267	276	288	276	251	251	251	276	251	247	267	275	276	267	296	268	275	247	275	275	288	285	yes	29096	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
276	R	365	252	268	277	289	277	252	252	252	277	252	248	268	276	277	268	297	269	276	248	276	276	289	286	yes	29099	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; Form hydrogen bond with Lys266 and Gln 272 [1] ;"		[1](10.1016/j.jmb.2007.02.069);
277	R	366	253	269	278	290	278	253	253	253	278	253	249	269	277	278	269	298	270	277	249	277	277	290	287	yes	29102	"T Cell Epitopes [1] ;  CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.1016/j.chom.2020.03.002); [2](10.1016/j.jmb.2007.02.069);
278	G	367	254	270	279	291	279	254	254	254	279	254	250	270	278	279	270	299	271	278	250	278	278	291	288	yes	29105	"CTD, hydrophobic, helix-rich terminal,  core stabilized by multiple hydrophobic interactions [1] ; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.1128/jvi.00017-07); [2](10.1016/j.jmb.2007.02.069;
279	P	368	255	271	280	292	280	255	255	255	280	255	251	271	279	280	271	300	272	279	251	279	279	292	289	yes	29108	"CTD, hydrophobic, helix-rich terminal, core stabilized by multiple hydrophobic interactions [1] ; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.1128/jvi.00017-07); [2](10.1016/j.jmb.2007.02.069;
280	E	369	256	272	281	293	281	256	256	256	281	256	252	272	280	281	272	301	273	280	252	280	280	293	290	yes	29111	"CTD, hydrophobic, helix-rich terminal, T cell epitope, Epitope HLA locus A subtype  24:02:00,  core stabilized by multiple hydrophobic interactions, extended b-strand [1] ; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [4] ; "		[1](10.1101/2020.03.30.01693c) ; [2](10.1016/j.chom.2020.03.002) ; [3](10.1128/jvi.00017-07) ; [4](10.1016/j.jmb.2007.02.069) ; [5](10.1007/s11373-005-9035-9) ;
281	Q	370	257	273	282	294	282	257	257	257	282	257	253	273	281	282	273	302	274	281	253	281	281	294	291	yes	29114	"B cell epitope region [1] ;  CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.1016/j.chom.2020.03.002); [2](10.1016/j.jmb.2007.02.069);
282	T	371	0	274	283	0	283	0	0	0	283	0	0	274	282	283	274	0	275	282	0	282	282	0	0	yes	29117	"B cell epitope region, Epitope HLA locus A subtype 11:01, core stabilized by multiple hydrophobic interactions, Phosphorylation site in IBV, B-cell epitope  HLA-A*03:01 HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-DRB1*01:01 (identical in SARS-CoV-2 and SARS-Cov) [1] ;  CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [4] ; "		[1](10.1101/2020.03.30.01693c) ; [2](10.1016/j.chom.2020.03.002) ; [3](10.1128/jvi.00017-07) ; [4](10.1016/j.jmb.2007.02.069) ; [5](10.1007/s11373-005-9035-9) ;  [6](10.3390/v12030254)
283	Q	372	0	275	284	0	284	0	0	0	284	0	0	275	283	284	275	0	276	283	0	283	283	0	0	yes	29120	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
284	G	373	0	276	285	0	285	0	0	0	285	0	0	276	284	285	276	0	277	284	0	284	284	0	0	yes	29123	"B cell epitope region [1];  Phosphorylation site in IBV [2];  CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [3] ; "		[1](10.1016/j.chom.2020.03.002 ) ;[2](10.1007/s11373-005-9035-9 ) ;[3](10.1016/j.jmb.2007.02.069);
285	N	374	258	277	286	295	286	258	258	258	286	258	254	277	285	286	277	303	278	285	254	285	285	295	292	yes	29126	"B cell epitope region [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions  [2] ; "		[1](10.1016/j.chom.2020.03.002 ) ;[2](10.1016/j.jmb.2007.02.069);
286	F	375	259	278	287	296	287	259	259	259	287	259	255	278	286	287	278	304	279	286	255	286	286	296	293	yes	29129	"B cell epitope region [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.1016/j.chom.2020.03.002 ) ;[2](10.1016/j.jmb.2007.02.069);
287	G	376	260	279	288	297	288	260	260	260	288	260	256	279	287	288	279	305	280	287	256	287	287	297	294	yes	29132	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
288	D	377	261	280	289	298	289	261	261	261	289	261	257	280	288	289	280	306	281	288	257	288	288	298	295	yes	29135	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
289	Q	378	262	281	290	299	290	262	262	262	290	262	258	281	289	290	281	307	282	289	258	289	289	299	296	no	29138	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ;  Form hydrogen bond with  Arg293 [3] ;"		[1](10.1016/j.jmb.2007.02.069);
290	E	379	263	282	291	300	291	263	263	263	291	263	259	282	290	291	282	308	283	290	259	290	290	300	297	no	29141	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
291	L	380	264	283	292	301	292	264	264	264	292	264	260	283	291	292	283	309	284	291	260	291	291	301	298	no	29144	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
292	I	381	265	284	293	302	293	265	265	265	293	265	261	284	292	293	284	310	285	292	261	292	292	302	299	no	29147	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
293	R	382	266	285	294	303	294	266	266	266	294	266	262	285	293	294	285	311	286	293	262	293	293	303	300	no	29150	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; Form hydrogen bond with  Gln289 [1] ;"		[1](10.1016/j.jmb.2007.02.069);
294	Q	383	267	286	295	304	295	267	267	267	295	267	263	286	294	295	286	312	287	294	263	294	294	304	301	no	29153	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
295	G	384	268	287	296	305	296	268	268	268	296	268	264	287	295	296	287	313	288	295	264	295	295	305	302	no	29156	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
296	T	385	269	288	297	306	297	269	269	269	297	269	265	288	296	297	288	314	289	296	265	296	296	306	303	no	29159	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
297	D	386	270	289	298	307	298	270	270	270	298	270	266	289	297	298	289	315	290	297	266	297	297	307	304	no	29162	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
298	Y	387	271	290	299	308	299	271	271	271	299	271	267	290	298	299	290	316	291	298	267	298	298	308	305	no	29165	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
299	K	388	272	291	300	309	300	272	272	272	300	272	268	291	299	300	291	317	292	299	268	299	299	309	306	no	29168	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
300	H	389	273	292	301	310	301	273	273	273	301	273	269	292	300	301	292	318	293	300	269	300	300	310	307	no	29171	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
301	W	390	274	293	302	311	302	274	274	274	302	274	270	293	301	302	293	319	294	301	270	301	301	311	308	no	29174	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
302	P	391	275	294	303	312	303	275	275	275	303	275	271	294	302	303	294	320	295	302	271	302	302	312	309	no	29177	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
303	Q	392	276	295	304	313	304	276	276	276	304	276	272	295	303	304	295	321	296	303	272	303	303	313	310	no	29180	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
304	I	393	277	296	305	314	305	277	277	277	305	277	273	296	304	305	296	322	297	304	273	304	304	314	311	no	29183	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[1] ; "		[1](10.1016/j.jmb.2007.02.069);
305	A	394	278	297	306	315	306	278	278	278	306	278	274	297	305	306	297	323	298	305	274	305	305	315	312	no	29186	"B-cell epitope, HLA-A*02:01 [1];  CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
306	Q	395	279	298	307	316	307	279	279	279	307	279	275	298	306	307	298	324	299	306	275	306	306	316	313	no	29189	"B-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
307	F	396	280	299	308	317	308	280	280	280	308	280	276	299	307	308	299	325	300	307	276	307	307	317	314	no	29192	"B-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
308	A	397	281	300	309	318	309	281	281	281	309	281	277	300	308	309	300	326	301	308	277	308	308	318	315	no	29195	"B-cell epitope, HLA-A*02:01, HLA-B*35:01 , HLA-B*51:01[1];  CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
309	P	398	282	301	310	319	310	282	282	282	310	282	278	301	309	310	301	327	302	309	278	309	309	319	316	no	29198	"B-cell epitope, HLA-A*02:01, HLA-B*35:01 , HLA-B*51:01[1];  CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
310	S	399	283	302	311	320	311	283	283	283	311	283	279	302	310	311	302	328	303	310	279	310	310	320	317	no	29201	"B-cell epitope,HLA-A*02:01, HLA-B*35:01 , HLA-B*51:01, HLA-A*03:01,HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ;  Form hydrogen bond with  residue 260 [2] ;"		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
311	A	400	284	303	312	321	312	284	284	284	312	284	280	303	311	312	303	329	304	311	280	311	311	321	318	no	29204	"B-cell epitope ,HLA-A*02:01, HLA-B*35:01 , HLA-B*51:01, HLA-A*03:01,HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
312	S	401	285	304	313	322	313	285	285	285	313	285	281	304	312	313	304	330	305	312	281	312	312	322	319	no	29207	"B-cell epitope,HLA-A*02:01, HLA-B*35:01 , HLA-B*51:01, HLA-A*03:01,HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
313	A	402	286	305	314	323	314	286	286	286	314	286	282	305	313	314	305	331	306	313	282	313	313	323	320	no	29210	"B-cell epitope ,HLA-A*02:01, HLA-B*35:01 , HLA-B*51:01, HLA-A*03:01,HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
314	F	403	287	306	315	324	315	287	287	287	315	287	283	306	314	315	306	332	307	314	283	314	314	324	321	no	29213	"B-cell epitope,HLA-A*02:01, HLA-B*35:01 , HLA-B*51:01, HLA-A*03:01,HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
315	F	404	288	307	316	325	316	288	288	288	316	288	284	307	315	316	307	333	308	315	284	315	315	325	322	no	29216	"B-cell epitope,  HLA-B*35:01 , HLA-B*51:01, HLA-A*03:01,HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
316	G	405	289	308	317	326	317	289	289	289	317	289	285	308	316	317	308	334	309	316	285	316	316	326	323	no	29219	"B-cell epitope,  HLA-B*35:01 , HLA-B*51:01, HLA-A*03:01,HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01, HLA-A*02:01[1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
317	M	406	290	309	318	327	318	290	290	290	318	290	286	309	317	318	309	335	310	317	286	317	317	327	324	no	29222	"B-cell epitope,  HLA-B*35:01 , HLA-B*51:01, HLA-A*03:01,HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01, HLA-A*02:01, HLA-DRB1*01:01 [1];  T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
318	S	407	291	310	319	328	319	291	291	291	319	291	287	310	318	319	310	336	311	318	287	318	318	328	325	no	29225	"B-cell epitope,  HLA-B*35:01 , HLA-B*51:01, HLA-A*03:01,HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01, HLA-A*02:01, HLA-DRB1*01:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
319	R	408	292	311	320	329	320	292	292	292	320	292	288	311	319	320	311	337	312	319	288	319	319	329	326	no	29228	"B-cell epitope, HLA-A*03:01,HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01, HLA-A*02:01, HLA-DRB1*01:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
320	I	409	293	312	321	330	321	293	293	293	321	293	289	312	320	321	312	338	313	320	289	320	320	330	327	no	29231	"B-cell epitope, HLA-A*03:01,HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01, HLA-A*02:01, HLA-DRB1*01:01 [1]; T-cell epitope, HLA-A*02:01 [1]; [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
321	G	410	294	313	322	331	322	294	294	294	322	294	290	313	321	322	313	339	314	321	290	321	321	331	328	no	29234	"B-cell epitope,  HLA-A*02:01, HLA-DRB1*01:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
322	M	411	295	314	323	332	323	295	295	295	323	295	291	314	322	323	314	340	315	322	291	322	322	332	329	no	29237	"B-cell epitope,  HLA-A*02:01, HLA-DRB1*01:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
323	E	412	296	315	324	333	324	296	296	296	324	296	292	315	323	324	315	341	316	323	292	323	323	333	330	no	29240	"B-cell epitope,  HLA-A*02:01, HLA-DRB1*01:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
324	V	413	297	316	325	334	325	297	297	297	325	297	293	316	324	325	316	342	317	324	293	324	324	334	331	no	29243	"B-cell epitope,  HLA-A*02:01, HLA-DRB1*01:01,HLA-A*01:01  [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
325	T	414	298	317	326	335	326	298	298	298	326	298	294	317	325	326	317	343	318	325	294	325	325	335	332	no	29246	"B-cell epitope,  HLA-DRB1*01:01, HLA-A*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01  [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
326	P	415	299	318	327	336	327	299	299	299	327	299	295	318	326	327	318	344	319	326	295	326	326	336	333	no	29249	"B-cell epitope,  HLA-DRB1*01:01, HLA-A*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01  [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
327	S	416	300	319	328	337	328	300	300	300	328	300	296	319	327	328	319	345	320	327	296	327	327	337	334	no	29252	"B-cell epitope,  HLA-DRB1*01:01, HLA-A*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01  [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
328	G	417	301	320	329	338	329	301	301	301	329	301	297	320	328	329	320	346	321	328	297	328	328	338	335	no	29255	"B-cell epitope,  HLA-DRB1*01:01, HLA-A*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01  [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
329	T	427	302	327	330	348	330	302	302	302	330	302	298	327	329	330	327	347	328	329	298	329	329	348	344	no	29258	"B-cell epitope,  HLA-DRB1*01:01, HLA-A*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01  [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
330	W	428	303	328	331	349	331	303	303	303	331	303	299	328	330	331	328	348	329	330	299	330	330	349	345	no	29261	"B-cell epitope,  HLA-DRB1*01:01, HLA-A*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01  [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
331	L	429	304	329	332	350	332	304	304	304	332	304	300	329	331	332	329	349	330	331	300	331	331	350	346	no	29264	"B-cell epitope,  HLA-DRB1*01:01, HLA-A*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01  [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
332	T	430	305	330	333	351	333	305	305	305	333	305	301	330	332	333	330	350	331	332	301	332	332	351	347	no	29267	"B-cell epitope,  HLA-A*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions  [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
333	Y	431	306	331	334	352	334	306	306	306	334	306	302	331	333	334	331	351	332	333	302	333	333	352	348	no	29270	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
334	T	432	307	332	335	353	335	307	307	307	335	307	303	332	334	335	332	352	333	334	303	334	334	353	349	no	29273	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
335	G	433	308	333	336	354	336	308	308	308	336	308	304	333	335	336	333	353	334	335	304	335	335	354	350	no	29276	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
336	A	434	309	334	337	355	337	309	309	309	337	309	305	334	336	337	334	354	335	336	305	336	336	355	351	no	29279	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
337	I	435	310	335	338	356	338	310	310	310	338	310	306	335	337	338	335	355	336	337	306	337	337	356	352	no	29282	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
338	K	436	311	336	339	357	339	311	311	311	339	311	307	336	338	339	336	356	337	338	307	338	338	357	353	no	29285	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
339	L	437	312	337	340	358	340	312	312	312	340	312	308	337	339	340	337	357	338	339	308	339	339	358	354	no	29288	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
340	D	438	313	338	341	359	341	313	313	313	341	313	309	338	340	341	338	358	339	340	309	340	340	359	355	no	29291	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
341	D	439	314	339	342	360	342	314	314	314	342	314	310	339	341	342	339	359	340	341	310	341	341	360	356	no	29294	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
342	K	440	315	340	343	361	343	315	315	315	343	315	311	340	342	343	340	360	341	342	311	342	342	361	357	no	29297	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
343	D	441	316	341	344	362	344	316	316	316	344	316	312	341	343	344	341	361	342	343	312	343	343	362	358	no	29300	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
344	P	442	317	342	345	363	345	317	317	317	345	317	313	342	344	345	342	362	343	344	313	344	344	363	359	no	29303	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
345	N	443	318	343	346	364	346	318	318	318	346	318	314	343	345	346	343	363	344	345	314	345	345	364	360	no	29306	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
346	F	444	0	344	347	365	347	0	0	0	347	0	0	344	346	347	344	0	345	346	0	346	346	365	361	no	29309	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
347	K	445	0	345	348	366	348	0	0	0	348	0	0	345	347	348	345	0	346	347	0	347	347	366	362	no	29312	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
348	D	446	0	346	349	367	349	0	0	0	349	0	0	346	348	349	346	0	347	348	0	348	348	367	363	no	29315	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
349	Q	447	0	347	350	368	350	0	0	0	350	0	0	347	349	350	347	0	348	349	0	349	349	368	364	no	29318	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
350	V	448	319	348	351	369	351	319	319	319	351	319	315	348	350	351	348	364	349	350	315	350	350	369	365	no	29321	" CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [1] ; "		[1](10.1016/j.jmb.2007.02.069);
351	I	449	320	349	352	370	352	320	320	320	352	320	316	349	351	352	349	365	350	351	316	351	351	370	366	no	29324	"B-cell epitope, HLA-A*02:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
352	L	450	321	350	353	371	353	321	321	321	353	321	317	350	352	353	350	366	351	352	317	352	352	371	367	no	29327	"B-cell epitope, HLA-A*02:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
353	L	451	322	351	354	372	354	322	322	322	354	322	318	351	353	354	351	367	352	353	318	353	353	372	368	no	29330	"B-cell epitope, HLA-A*02:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
354	N	452	323	352	355	373	355	323	323	323	355	323	319	352	354	355	352	368	353	354	319	354	354	373	369	no	29333	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
355	K	453	324	353	356	374	356	324	324	324	356	324	320	353	355	356	353	369	354	355	320	355	355	374	370	no	29336	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
356	H	454	325	354	357	375	357	325	325	325	357	325	321	354	356	357	354	370	355	356	321	356	356	375	371	no	29339	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
357	I	455	326	355	358	376	358	326	326	326	358	326	322	355	357	358	355	371	356	357	322	357	357	376	372	no	29342	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
358	D	456	327	356	359	377	359	327	327	327	359	327	323	356	358	359	356	372	357	358	323	358	358	377	373	no	29345	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
359	A	457	328	357	360	378	360	328	328	328	360	328	324	357	359	360	357	373	358	359	324	359	359	378	374	no	29348	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01 [1]; T-cell epitope, HLA-A*02:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
360	Y	458	329	358	361	379	361	329	329	329	361	329	325	358	360	361	358	374	359	360	325	360	360	379	375	no	29351	"B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01 [1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
361	K	459	330	359	362	0	362	330	330	330	362	330	326	359	361	362	359	375	360	361	326	361	361	0	376	no	29354	"B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
362	T	460	331	360	363	0	363	331	331	331	363	331	327	360	362	363	360	376	361	362	327	362	362	0	377	no	29357	"B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; Region binding to RNA [2] ;"		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
363	F	461	332	361	364	0	364	332	332	332	364	332	328	361	363	364	361	377	362	363	328	363	363	0	0	no	29360	"B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions[2] ; Region binding to RNA [2] ;"		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
364	P	462	333	362	365	0	365	333	333	333	365	333	329	362	364	365	362	378	363	364	329	364	364	0	0	no	29363	"B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1]; CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions [2] ; Region binding to RNA [2] ; nuclear localization signal (NLS) [3];"		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069);
365	P	463	334	363	366	0	366	334	334	334	366	334	330	363	365	366	363	379	364	365	330	365	365	0	0	no	29366	"B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1];  CTD dimerization domain , core  domain stabilized by multiple hydrophobic interactions  [2] ; Region binding to RNA [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
366	T	464	335	364	367	0	367	335	335	335	367	335	331	364	366	367	364	380	365	366	331	366	366	0	0	no	29369	"B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1]; core  domain stabilized by multiple hydrophobic interactions [2]; Region binding to RNA [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
367	E	465	336	365	368	0	368	336	336	336	368	336	332	365	367	368	365	381	366	367	332	367	367	0	0	no	29372	"B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1]; core  domain stabilized by multiple hydrophobic interactions [2] ; Region binding to RNA [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
368	P	466	337	366	369	0	369	337	337	337	369	337	333	366	368	369	366	382	367	368	333	368	368	0	0	no	29375	"B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1]; core  domain stabilized by multiple hydrophobic interactions [2] ; Region binding to RNA [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
369	K	467	338	367	370	0	370	338	338	338	370	338	334	367	369	370	367	383	368	369	334	369	369	0	0	no	29378	"B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1]; core  domain stabilized by multiple hydrophobic interactions [2] ; Region binding to RNA [2]  ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
370	K	468	339	368	371	380	371	339	339	339	371	339	335	368	370	371	368	384	369	370	335	370	370	380	378	no	29381	"B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1]; Region binding to RNA [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
371	D	469	340	369	372	0	372	340	340	340	372	340	336	369	371	372	369	385	370	371	336	371	371	381	379	no	29384	"B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1]; Region binding to RNA [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
372	K	483	341	372	373	381	373	341	341	341	373	341	337	372	372	373	372	386	384	372	337	372	372	382	380	no	29387	" B-cell epitope, HLA-DRB1*01:01 [1]; Region binding to RNA [2] ; intrinsically disordered regions (IDR) [3]; "		[1](10.3390/v12030254) ; [2](10.1016/j.jmb.2007.02.069); [3](10.3390/v6082991); 
373	K	484	342	373	374	382	374	342	342	342	374	342	338	373	373	374	373	387	385	373	338	373	373	383	381	no	29390	 Region binding to RNA [1] ; intrinsically disordered regions (IDR) [2]; 		 [1](10.1016/j.jmb.2007.02.069); [2](10.3390/v6082991); 
374	K	485	343	374	375	383	375	343	343	343	375	343	339	374	374	375	374	388	386	374	339	374	374	384	382	no	29393	 Region binding to RNA [1] ; intrinsically disordered regions (IDR) [2]; 		 [1](10.1016/j.jmb.2007.02.069); [2](10.3390/v6082991); 
375	K	486	344	375	376	384	376	344	344	344	376	344	340	375	375	376	375	389	387	375	340	375	375	385	383	no	29396	 Region binding to RNA [1] ; intrinsically disordered regions (IDR) [2]; 		 [1](10.1016/j.jmb.2007.02.069); [2](10.3390/v6082991); 
376	A	487	345	376	377	385	377	345	345	345	377	345	341	376	376	377	376	390	388	376	341	376	376	386	384	no	29399	 Region binding to RNA [1] ; intrinsically disordered regions (IDR) [2]; 		 [1](10.1016/j.jmb.2007.02.069); [2](10.3390/v6082991); 
377	D	488	346	377	378	386	378	346	346	346	378	346	342	377	377	378	377	391	389	377	342	377	377	387	385	no	29402	 Region binding to RNA [1] ; intrinsically disordered regions (IDR) [2]; 		 [1](10.1016/j.jmb.2007.02.069); [2](10.3390/v6082991); 
378	E	489	347	378	379	387	379	347	347	347	379	347	343	378	378	379	378	392	390	378	343	378	378	388	386	no	29405	 Region binding to RNA [1] ; intrinsically disordered regions (IDR) [2]; 		 [1](10.1016/j.jmb.2007.02.069); [2](10.3390/v6082991); 
379	T	490	348	379	380	388	380	348	348	348	380	348	344	379	379	380	379	393	391	379	344	379	379	389	387	no	29408	 Region binding to RNA [1] ; intrinsically disordered regions (IDR) [2]; 		 [1](10.1016/j.jmb.2007.02.069); [2](10.3390/v6082991); 
380	Q	491	349	380	381	389	381	349	349	349	381	349	345	380	380	381	380	394	392	380	345	380	380	390	388	no	29411	 Region binding to RNA [1] ; intrinsically disordered regions (IDR) [2]; 		 [1](10.1016/j.jmb.2007.02.069); [2](10.3390/v6082991); 
381	A	492	350	381	382	390	382	350	350	0	382	350	346	381	381	382	381	395	393	381	346	381	381	391	389	no	29414	 Region binding to RNA [1] ; intrinsically disordered regions (IDR) [2]; 		 [1](10.1016/j.jmb.2007.02.069); [2](10.3390/v6082991); 
382	L	493	351	382	383	391	383	351	351	0	383	351	347	382	382	383	382	396	394	382	347	382	382	392	390	no	29417	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
383	P	494	352	383	384	392	384	352	352	0	384	352	348	383	383	384	383	397	395	383	348	383	383	393	391	no	29420	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
384	Q	495	353	384	385	393	385	353	353	0	385	353	349	384	384	385	384	398	396	384	349	384	384	394	392	no	29423	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
385	R	496	354	385	386	394	386	354	354	0	386	354	350	385	385	386	385	399	397	385	350	385	385	395	393	no	29426	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
386	Q	497	355	386	387	395	387	355	355	0	387	355	351	386	386	387	386	400	398	386	351	386	386	396	394	no	29429	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
387	K	498	0	387	388	396	388	0	0	0	388	0	0	387	387	388	387	401	399	387	0	387	387	397	395	no	29432	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
388	K	499	0	388	389	397	389	0	0	0	389	0	0	388	388	389	388	402	400	388	0	388	388	398	396	no	29435	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
389	Q	500	0	389	390	398	390	0	0	0	390	0	0	389	389	390	389	403	401	389	0	389	389	399	397	no	29438	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
390	Q	501	0	390	391	399	391	0	0	0	391	0	0	390	390	391	390	404	402	390	0	390	390	400	398	no	29441	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
391	T	502	0	0	392	400	392	0	0	0	392	0	0	391	391	392	391	405	403	391	0	391	391	401	399	no	29444	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
392	V	503	0	0	393	401	393	0	0	0	393	0	0	392	392	393	392	406	404	392	0	392	392	402	0	no	29447	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
393	T	504	0	391	394	402	394	0	0	0	394	0	0	393	393	394	393	407	405	393	0	393	393	403	0	no	29450	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
394	L	505	0	392	395	403	395	0	0	0	395	0	0	394	394	395	394	408	406	394	0	394	394	404	400	no	29453	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
395	L	506	0	393	396	404	396	0	0	0	396	0	0	395	395	396	395	409	407	395	0	395	395	405	401	no	29456	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
396	P	507	0	0	397	405	397	0	0	0	397	0	0	0	396	397	0	410	0	396	0	396	396	406	402	no	29459	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
397	A	508	0	0	398	406	398	0	0	0	398	0	0	0	397	398	0	411	0	397	0	397	397	407	403	no	29462	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
398	A	509	356	0	399	407	399	356	356	350	399	356	0	0	398	399	0	412	0	398	0	398	398	408	404	no	29465	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
399	D	510	357	0	400	408	400	357	357	351	400	357	352	0	399	400	0	413	0	399	352	399	399	409	405	no	29468	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
400	L	511	358	0	401	409	401	358	358	352	401	358	353	0	400	401	0	414	0	400	353	400	400	410	406	no	29471	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
401	D	512	359	0	402	410	402	359	359	353	402	359	354	0	401	402	0	415	0	401	354	401	401	411	407	no	29474	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
402	D	513	360	0	403	411	403	360	360	354	403	360	355	0	402	403	0	416	0	402	355	402	402	412	408	no	29477	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
403	F	514	361	0	404	412	404	361	361	355	404	361	356	0	403	404	0	417	0	403	356	403	403	413	409	no	29480	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
404	S	515	362	394	405	413	405	362	362	356	405	362	357	396	404	405	396	418	408	404	357	404	404	414	0	no	29483	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
405	K	516	363	395	406	414	406	363	363	357	406	363	358	397	405	406	397	419	409	405	358	405	405	415	0	no	29486	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
406	Q	517	364	396	407	415	407	364	364	358	407	364	359	398	406	407	398	420	410	406	359	406	406	416	0	no	29489	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
407	L	518	365	397	408	416	408	365	365	359	408	365	360	399	407	408	399	421	411	407	360	407	407	417	0	no	29492	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
408	Q	519	366	398	409	417	409	366	366	360	409	366	361	400	408	409	400	422	412	408	361	408	408	418	410	no	29495	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
409	Q	520	367	399	410	418	410	367	367	361	410	367	362	401	409	410	401	423	413	409	362	409	409	419	411	no	29498	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
410	S	521	368	400	411	419	411	368	368	362	411	368	363	402	410	411	402	424	414	410	363	410	410	420	412	no	29501	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
411	M	522	369	401	412	420	412	369	369	363	412	369	364	403	411	412	403	425	415	411	364	411	411	421	413	no	29504	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
412	S	523	370	402	413	421	413	370	370	364	413	370	365	404	412	413	404	426	0	412	365	412	412	422	414	no	29507	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
413	S	524	371	403	414	422	414	371	371	365	414	371	366	405	413	414	405	427	0	413	366	413	413	423	415	no	29510	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
414	A	528	374	406	417	425	417	374	374	369	417	374	369	408	414	417	408	430	0	414	369	416	414	426	418	no	29513	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
415	D	529	375	407	418	426	418	375	375	370	418	375	370	409	415	418	409	431	416	415	370	417	415	427	419	no	29516	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
416	S	530	376	408	419	427	419	376	376	371	419	376	371	410	416	419	410	432	417	416	371	418	416	428	420	no	29519	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
417	T	531	377	409	420	428	420	377	377	372	420	377	372	411	417	420	411	433	418	417	372	419	417	429	421	no	29522	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
418	Q	532	378	410	421	429	421	378	378	373	421	378	373	412	418	421	412	434	419	418	373	420	418	430	422	no	29525	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 
419	A	533	379	411	422	430	422	379	379	374	422	379	374	413	419	422	413	435	420	419	374	421	419	431	423	no	29528	intrinsically disordered regions (IDR) [1]; 		[1](10.3390/v6082991); 